dual RAR/RXR agonist (Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual RAR/RXR agonist (Novartis)
Drug Alias Namedual retinoid acid receptor/retinoid X receptor agonist (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha agonistsRetinoid X receptor alpha agonists
TargetsRetinoid X receptor alphaRetinoic acid receptor alpha
Therapy Area/IndicationsLeukemia, Promyelocytic, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Institutes For Biomedical Research Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Promyelocytic, Acute

Other Information

ATC CodeN/A
Related LinksN/A